Qingxi Wang
Director/Board Member bei CSPC PHARMACEUTICAL GROUP LTD.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Qingxi Wang is currently the Chairman & Chief Executive Officer at Conjupro Biotherapeutics, Inc. and an Executive Director at CSPC Pharmaceutical Group Ltd.
Previously, he worked as a Director of Operations & Business Development at Merck & Co., Inc. Dr. Wang holds a Master's in Business Administration from Temple University, a graduate and doctorate degree from the University of Connecticut, and undergraduate and graduate degrees from Nankai University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.11.2023 | 3 000 000 ( 0,03% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Qingxi Wang
| Unternehmen | Position | Beginn |
|---|---|---|
| CSPC PHARMACEUTICAL GROUP LTD. | Director/Board Member | 20.08.2018 |
Conjupro Biotherapeutics, Inc.
 Conjupro Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Conjupro Biotherapeutics, Inc. is a biopharmaceutical company that specializes in clinical research and drug development. The company is based in Princeton, NJ. Qingxi Wang has been the CEO of the company since 2016. | Chief Executive Officer | 01.01.2016 |
Ehemalige bekannte Positionen von Qingxi Wang
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK & CO., INC. | Chief Operating Officer | - |
Ausbildung von Qingxi Wang
| Temple University (Pennsylvania) | Masters Business Admin |
| University of Connecticut | Doctorate Degree |
| Nankai University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| CSPC PHARMACEUTICAL GROUP LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Conjupro Biotherapeutics, Inc. is a biopharmaceutical company that specializes in clinical research and drug development. The company is based in Princeton, NJ. Qingxi Wang has been the CEO of the company since 2016. | Commercial Services |
